Log in

Relevant bibliographies by topics / Diabetes – Treatment / Journal articles

Journal articles on the topic 'Diabetes – Treatment'

To see the other types of publications on this topic, follow the link: Diabetes – Treatment.

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diabetes – Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Mammen, Dr Sheena A. "Knowledge of Diabetes, its Treatment and Complications in Diabetic Patients." Journal of Medical Science And clinical Research 05, no. 05 (May 12, 2017): 21838–40. http://dx.doi.org/10.18535/jmscr/v5i5.99.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khalid Iqbal, Rana. "Type 2 Diabetes and its Treatment." Diabetes & Obesity International Journal 4, no. 3 (2019): 1–3. http://dx.doi.org/10.23880/doij-16000208.

Full text

Abstract:

Type 2 diabetes is chronic disease that is spreading all over the world. In type 2 diabetes mainly there is less insulin production. It can be diet-induced and may also be associated with obesity. The body weight of a person increases due to more energy taken by the food, also the physical activity with less workout may lead to abdominal adiposity and finally the insulin resistance. Insulin resistance leads to the development of type 2 diabetes. The ratio of diabetic patients is increasing day by day. 90% of the total diabetic patients have type 2 diabetes. The risk of developing type 2diabetes is increasing according to an estimation of the American born in 2000 or later one of the three and some 50% members are expected to have type 2 diabetes.

APA, Harvard, Vancouver, ISO, and other styles

3

Bloomgarden, Z. T. "Diabetes Treatment." Diabetes Care 32, no. 3 (February 26, 2009): e25-e30. http://dx.doi.org/10.2337/dc09-zb03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

&NA;. "Diabetes Treatment Breakthroughs." American Journal of Nursing 98, no. 10 (October 1998): 56. http://dx.doi.org/10.1097/00000446-199810000-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kuehn, Bridget M. "Diabetes Treatment Doubles." JAMA 305, no. 8 (February 23, 2011): 770. http://dx.doi.org/10.1001/jama.2011.182.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Luo, Juhua, Beth Virnig, Michael Hendryx, Sijin Wen, Rowan Chelebowski, Chu Chen, Tomas Rohan, et al. "Diabetes, diabetes treatment and breast cancer prognosis." Breast Cancer Research and Treatment 148, no. 1 (September 27, 2014): 153–62. http://dx.doi.org/10.1007/s10549-014-3146-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sung, Hsing-Wen, Kiran Sonaje, and Si-Shen Feng. "Nanomedicine for diabetes treatment." Nanomedicine 6, no. 8 (October 2011): 1297–300. http://dx.doi.org/10.2217/nnm.11.124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Fowler, M. J. "Diabetes Treatment: Oral Agents." Clinical Diabetes 28, no. 3 (June 1, 2010): 132–36. http://dx.doi.org/10.2337/diaclin.28.3.132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Deepika, V., L. Harsha, and Aishwarya Ravishankar. "Treatment of Diabetes Insipidus." Research Journal of Pharmacy and Technology 8, no. 6 (2015): 767. http://dx.doi.org/10.5958/0974-360x.2015.00123.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Oba, Kenzo. "Treatment guide for diabetes." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 48, no. 6 (2011): 640–43. http://dx.doi.org/10.3143/geriatrics.48.640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Gadsby, Roger. "Insulin treatment in diabetes." InnovAiT: Education and inspiration for general practice 6, no. 6 (June 2013): 344–48. http://dx.doi.org/10.1177/1755738013480763.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Schlechte, Janet. "Treatment Guides for Diabetes." Endocrinologist 5, no. 1 (January 1995): 81. http://dx.doi.org/10.1097/00019616-199501000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Schlechte, Janet. "Treatment Guides for Diabetes." Endocrinologist 5, no. 1 (January 1995): 81. http://dx.doi.org/10.1097/00019616-199501000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

&NA;. "Treatment Guides for Diabetes." Endocrinologist 5, no. 1 (January 1995): 81. http://dx.doi.org/10.1097/00019616-199501000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

&NA;. "Treatment Guides for Diabetes." Endocrinologist 5, no. 1 (January 1995): 81. http://dx.doi.org/10.1097/00019616-199501000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

&NA;. "Diabetes Treatment and Research." Endocrinologist 8, no. 2 (March 1998): 108. http://dx.doi.org/10.1097/00019616-199803000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Gadsby, Roger. "Insulin Treatment in Diabetes." InnovAiT: Education and inspiration for general practice 2, no. 12 (November 17, 2009): 708–12. http://dx.doi.org/10.1093/innovait/inp170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Hollander, Priscilla A. "Advances in Diabetes Treatment." Baylor University Medical Center Proceedings 10, no. 4 (October 1997): 179–84. http://dx.doi.org/10.1080/08998280.1997.11930058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Jabeen, Mah. "Insulin treatment for diabetes." InnovAiT: Education and inspiration for general practice 13, no. 12 (October 8, 2020): 739–46. http://dx.doi.org/10.1177/1755738020958752.

Full text

Abstract:

The first use of insulin in 1922 began a new era in the management and survival of patients with type 1 diabetes. Before 1922, patients with this condition were placed on a starvation diet and survived only a few months. Nearly a century later, insulin remains the dominant treatment for type 1 diabetes, is used in gestational diabetes and increasingly in type 2 diabetes. This article focuses on insulin treatment for adult diabetic patients in general practice. It will explore the effect of insulin and the role it has in diabetes, the preparations available, recommended regimens and some challenges with insulin treatment.

APA, Harvard, Vancouver, ISO, and other styles

20

Nielsen, Jannie, Silver K. Bahendeka, Ib C. Bygbjerg, Dan W. Meyrowitsch, and Susan R. Whyte. "Diabetes Treatment as “Homework”." Health Education & Behavior 43, no. 1_suppl (March 31, 2016): 100S—111S. http://dx.doi.org/10.1177/1090198115610569.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Egerton, June, and Margaret Bardle. "Group treatment in diabetes." Practice Nursing 10, no. 19 (November 16, 1999): 29–31. http://dx.doi.org/10.12968/pnur.1999.10.19.29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Smith, Richard M., and Tom E. Mandel. "Transplantation treatment for diabetes." Immunology Today 19, no. 10 (October 1998): 444–47. http://dx.doi.org/10.1016/s0167-5699(98)01323-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

The Lancet. "“Breakthrough” in diabetes treatment?" Lancet 365, no. 9464 (March 2005): 1004. http://dx.doi.org/10.1016/s0140-6736(05)71114-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

KANEKO, TOSHIO. "Treatment of diabetes mellitus." Nihon Naika Gakkai Zasshi 82, no. 9 (1993): 1499–503. http://dx.doi.org/10.2169/naika.82.1499.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Handfield-Jones, S., S. K. Jones, and R. D. G. Peachey. "Nicotinamide treatment in diabetes." British Journal of Dermatology 116, no. 2 (February 1987): 277. http://dx.doi.org/10.1111/j.1365-2133.1987.tb05829.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Meltzer, S. J. "Treatment of gestational diabetes." BMJ 340, apr01 1 (April 1, 2010): c1708. http://dx.doi.org/10.1136/bmj.c1708.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Cohen, N. D., and J. E. Shaw. "Diabetes: advances in treatment." Internal Medicine Journal 37, no. 6 (May 24, 2007): 383–88. http://dx.doi.org/10.1111/j.1445-5994.2007.01369.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Robertson, R. P., and D. J. Klein. "Treatment of diabetes mellitus." Diabetologia 35, S2 (December 1992): S8—S17. http://dx.doi.org/10.1007/bf00586274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Veves, Aristidis, Dimitrios Baltzis, and Ioanna Eleftheriadou. "Diabetes Treatment: Recent Developments." Advances in Therapy 30, no. 12 (November 22, 2013): 1031–32. http://dx.doi.org/10.1007/s12325-013-0073-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Bensimhon, Hannah F., and Matthew A. Cavender. "Hypertension Treatment in Diabetes." Heart Failure Clinics 15, no. 4 (October 2019): 551–63. http://dx.doi.org/10.1016/j.hfc.2019.06.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kennedy, Richard L., Venkat Vangaveti, and Usman H. Malabu. "Statin Treatment and Diabetes." Journal of the American College of Cardiology 61, no. 18 (May 2013): 1933–34. http://dx.doi.org/10.1016/j.jacc.2013.01.071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Makhmudov, Nurillo, and Zukhra Kosimova. "Diagnosis And Treatment Of Emphysematous Pyelonephritis In Patients With Diabetes." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 01 (January 24, 2021): 87–90. http://dx.doi.org/10.37547/tajmspr/volume03issue01-13.

Full text

Abstract:

In this study we report on our experience in treating two patients diagnosed with a rare disease of emphysematous pyelonephritis, who were admitted to the Urology department of Fergana Medical Institute during 2018. We provide details on each test conducted on patients, pre- and post-surgery. Our analysis shows that to prevent complications in patients with diabetes mellitus, dispensary observation with control of glucose levels, urine and blood tests is necessary.

APA, Harvard, Vancouver, ISO, and other styles

33

J, Belloni, and Tapper X. "Glp-1 Analogs for the Treatment of Obesity and Diabetes." Endocrinology and Disorders 6, no. 2 (May 30, 2022): 01–06. http://dx.doi.org/10.31579/2640-1045/116.

Full text

Abstract:

Currently the prevalence of obesity and diabetes is increasing throughout the world. The unsatisfactory long-term results observed in the treatment of both are due to their complex pathophysiologies and the difficulties related to maintaining lifestyle changes. From the knowledge of the incretin effect and its alteration in patients with type 2 diabetes mellitus, GLP-1 receptor agonists arise, molecules with high structural homology with native GLP-1. Scientific evidence supports its use for the long-term treatment of diabetes, especially in the presence of associated cardiovascular and/or renal failure. In 2009, the use of liraglutide for patients with diabetes was approved in Europe, and in 2014 it was signed for the first time in the United States to treat obesity, since it was observed that the use of these drugs causes significant weight loss.

APA, Harvard, Vancouver, ISO, and other styles

34

Al-Suhaimi, Ebtesam Abdullah. "From the Tap to Treatment: Water's Influence on Diabetes Control." Diabetes & Obesity International Journal 8, no. 4 (2023): 1–2. http://dx.doi.org/10.23880/doij-16000276.

Full text

Abstract:

Recent research explores the potential influence of drinking water, including mineral water, on glycemic parameters in individuals with and without type 2 diabetes. Heterogeneous findings emphasize the complexity of the issue. Meta-analyses and prospective cohort studies suggest potential positive effects, particularly when replacing sugary beverages with water or incorporating bicarbonate, magnesium-rich water. Conversely, concerns arise regarding the impact of certain water minerals like fluoride and arsenic on diabetes rates. Larger, rigorous trials are needed for definitive conclusions. This research informs healthcare professionals, policymakers, and individuals about water, minerals, and glycemic control in diabetes management.

APA, Harvard, Vancouver, ISO, and other styles

35

Krejčí, Hana, Jan Vyjídák, and Matej Kohutiar. "Low-carbohydrate diet in diabetes mellitus treatment." Vnitřní lékařství 64, no. 7-8 (July 1, 2018): 742–52. http://dx.doi.org/10.36290/vnl.2018.102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Luo, Juhua, Lawrence Phillips, Simin Liu, Jean Wactawski-Wende, and Karen L. Margolis. "Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer." Journal of Clinical Endocrinology & Metabolism 101, no. 3 (March 2016): 1243–48. http://dx.doi.org/10.1210/jc.2015-3901.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Chilton, P. M., F. Rezzoug, I. Fugier-Vivier, L. A. Weeter, H. Xu, Y. Huang, M. B. Ray, and S. T. Ildstad. "Flt3-Ligand Treatment Prevents Diabetes in NOD Mice." Diabetes 53, no. 8 (July 26, 2004): 1995–2002. http://dx.doi.org/10.2337/diabetes.53.8.1995.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

S.A., Abdullaev, Yuldashev F.Sh., Dusiyarov M.M., and Khuzhaboev S.T. "TREATMENT OF PURULENT-NECROTIC COMPLICATIONS OF SOFT TISSUES IN DIABETES MELLITUS." American Journal of Medical Sciences and Pharmaceutical Research 5, no. 9 (September 1, 2023): 15–22. http://dx.doi.org/10.37547/tajmspr/volume05issue09-04.

Full text

Abstract:

One of the frequent complications of diabetes mellitus (DM) is the lesion of human blood vessels, leading to the development of diabetic foot. Literature and daily practical observation show an increase of the rate of diabetic foot (30-70%), which raises the actuality of the problem of diabetic foot treatment. This article contains data concerning the results of surgical treatment of 151 patients with diabetes mellitus complicated by diabetic foot and purulent-necrotic soft tissue inflammation. Our work presents the basic principles of treatment of purulent-necrotic complications of diabetes mellitus. The effectiveness of local application of Acerbin solution and two-stage surgical tactics in the complex surgical treatment of purulent-necrotic complications of diabetes mellitus has been proved.

APA, Harvard, Vancouver, ISO, and other styles

39

Bradley, B., S. J. Prowse, P. Bauling, and K. J. Lafferty. "Desferrioxamine treatment prevents chronic islet allograft damage." Diabetes 35, no. 5 (May 1, 1986): 550–55. http://dx.doi.org/10.2337/diabetes.35.5.550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Reichard, P., and M. Pihl. "Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study." Diabetes 43, no. 2 (February 1, 1994): 313–17. http://dx.doi.org/10.2337/diabetes.43.2.313.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Chinnaboina, Gopala Krishna, AMS SudhakarBabu, Rajesh Verma, Pankaj Sharma, and Birendra Shrivastava. "A Review on Diabetes Mellitus Current Update on Management and Treatment." Asian Pacific Journal of Health Sciences 5, no. 3 (July 2018): 147–62. http://dx.doi.org/10.21276/apjhs.2018.5.3.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Islam, KA, M. Hossain, BK Choudhury, N. Alam, SI Joy, and S. Hossain. "An Alternative Treatment of Diabetes with Ganoderma lucidum: A Case Report." Series of Clinical and Medical Case Reports and Reviews 2, no. 1 (March 15, 2024): 1–7. http://dx.doi.org/10.54178/2993-3579.v2i1a2027.

Full text

Abstract:

Ganoderma lucidum (L) is considered an effective medicinal mushroom. The main goal of this research was to investigate whether the beneficial effects of G. lucidum found in various in vitro or animal studies can be translated to chronic metabolic diseases such as diabetes in humans. Here, we present a case study of a person with diabetes after treatment with G. lucidum and provide important information on fasting blood glucose (FG) levels, glycated hemoglobin (HbA1c), lipid profile, and various other blood parameters. After taking G. lucidum hot water extract for three months, FG levels decreased from 198 mg/dL to 177.3 mg/dL. HbA1c fell by 1.5%. Serum total cholesterol (TC) decreased from 210 to 170 mg/dL, and triglyceride (TG) levels decreased from 220 to 150 mg/dL, while serum high-density cholesterol (HDL-C) increased from 25 to 35 mg/dL. Low-density cholesterol (LDL-C) only decreased by 9 mg/dL. Serum creatinine, alkaline phosphatase (ALP), alanine aminotransferase (ALT), and total bilirubin levels were not changed. Therefore, it is concluded that G. lucidum hot water extract had antidiabetic and antidyslipidemic effects without affecting hepatorenal functions.

APA, Harvard, Vancouver, ISO, and other styles

43

Arslan, Alparslan, and Mine Dosay-Akbulut. "Diabetes and Alternative Treatment Models." Journal of Advances in Biology & Biotechnology 26, no. 10 (December 9, 2023): 39–58. http://dx.doi.org/10.9734/jabb/2023/v26i10662.

Full text

Abstract:

Diabetes Mellitus is a collection of various conditions that have resulted in an increase in blood glucose levels. This article outlines the current classification of diabetes mellitus and compares the majority of the characteristics of both type 1 and 2 diabetes. Fasting and oral glucose resistance tests and legitimate biochemical demonstrative criteria when utilizing hemoglobin A1c (HbA1c) are moreover summarized. Rising rates of diabetes require focused on screening to distinguish diabetes and prediabetes in at-risk bunches. In order to prevent the development of diabetes in these random clusters and delay its progression, it is necessary to engage in early physical activity after that initial activity has occurred. Concurring to the most recent information from The International Diabetes Federation (IDF) in 2021, the number of grown-up patients matured 20-79 a long time around the world is over 500 million and this number will increment to 800 million within the 2050s. Diabetes is also a costly disease that consumes about 12% of healthcare costs globally. Considering the undesirable side effects and costs of known standard treatments; Today, the tendency and preference possibilities for alternative therapies (CAM) are increasing day by day. Herbal medicines, in other words, alternative treatments are the traditional methods used in the treatment of many diseases, which are mostly preferred especially within Eastern and Middle Eastern countries. In this study, possible alternative treatment models and sources of active substances were presented, and the possibilities and studies for more effective treatment of diabetes were summarized and tried to be put forward.

APA, Harvard, Vancouver, ISO, and other styles

44

&NA;. "Diabetes, diabetes treatment affect cognitive function in elderly women." Inpharma Weekly &NA;, no. 1427 (March 2004): 19. http://dx.doi.org/10.2165/00128413-200414270-00044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

GOTO, YOSHIO. "Internal secretions, metabloloism, diabetes mellitus. Treatment of diabetes mellitus." Nihon Naika Gakkai Zasshi 79, no. 3 (1990): 317–21. http://dx.doi.org/10.2169/naika.79.317.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Vaughan, N. J. A., and Nigel W. Oakley. "Treatment of Diabetes in Pregnancy." Clinics in Obstetrics and Gynaecology 13, no. 2 (June 1986): 291–306. http://dx.doi.org/10.1016/s0306-3356(21)00014-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Marcovecchio, M. Loredana. "Treatment Options for Pediatric Diabetes." US Endocrinology 14, no. 1 (2018): 20. http://dx.doi.org/10.17925/use.2018.14.1.20.

Full text

Abstract:

The needs of pediatric patients with diabetes differ from those of adults. Challenges include growth and development, and care outside of the home, such as in the school setting. In addition, in type 2 diabetes, there are fewer treatment options for pediatric patients; while recent years have seen the approval of many glucose-lowering drugs for adults, only metformin and insulin are approved in patients aged under 18 years. In an expert interview, M Loredana Marcovecchio, of the University of Cambridge, UK, discusses recent advances and remaining challenges in the treatment of pediatric patients with both type 1 and type 2 diabetes.

APA, Harvard, Vancouver, ISO, and other styles

48

Davidson, H. Edward. "Improving the Treatment of Diabetes." Consultant Pharmacist 29, no. 5 (May 1, 2014): 282. http://dx.doi.org/10.4140/tcp.n.2014.282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

&NA;. "Oral treatment for diabetes mellitus?" Inpharma Weekly &NA;, no. 1192 (June 1999): 8. http://dx.doi.org/10.2165/00128413-199911920-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Buse, J. "Statin Treatment in Diabetes Mellitus." Clinical Diabetes 21, no. 4 (October 1, 2003): 168–72. http://dx.doi.org/10.2337/diaclin.21.4.168.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!